B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gefitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gefitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

erlotinib
60 shared targets
canertinib
59 shared targets
vandetanib
50 shared targets
pelitinib
44 shared targets
Afatinib
33 shared targets · score 50.1
cediranib
37 shared targets
doramapimod
37 shared targets
neratinib
40 shared targets
foretinib
58 shared targets
nilotinib
30 shared targets
Loading evidence profile...

This evidence profile for Gefitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.